Rheumatoid Arthritis News

PHILADELPHIA — Among patients with rheumatoid arthritis who had an inadequate response or intolerance to TNF inhibitors, upadacitinib demonstrated clinically meaningful and improved efficacy over 24 weeks, according to a post-hoc analysis.

PHILADELPHIA — Patients with rheumatoid arthritis frequently switched between JAK inhibitors in Australia, according to a presentation at ACR Convergence 2022.

PHILADELPHIA — There is “no clear increased risk” for major adverse cardiovascular events associated with tofacitinib, according to a post-hoc analysis of the ORAL Surveillance trial presented at ACR Convergence 2022.

PHILADELPHIA — A daily glucocorticoid dose higher than 2.5 mg may lead to irreversible bone mineral density loss regardless of intervention with osteoporosis medications, according to data presented at ACR Convergence 2022.

New guidance from the American College of Rheumatology strongly recommends that patients with rheumatoid arthritis engage in physical exercise when possible.

The ongoing development of splenic nerve stimulation has continued to provide a window into the potential future of bioelectronics in medicine, according to Kristoffer Famm, PhD, president of Galvani Bioelectronics, based in the U.K.

PHILADELPHIA — A novel therapy targeting human programmed cell death protein-1 showed efficacy in rheumatoid arthritis with an attractive safety profile, according to a speaker at ACR Convergence 2022.

PHILADELPHIA — Patients who switched from one infliximab biosimilar to another experienced comparable treatment retention rates, according to data presented at ACR Convergence 2022.

PHILADELPHIA — Rheumatologists are unlikely to be held liable under a state’s anti-abortion laws for prescribing methotrexate for a rheumatic disease, according to a law professor who spoke at ACR Convergence 2022.

PHILADELPHIA — Discontinuing methotrexate for 1 week after influenza vaccination offers similar seroprotection as pausing for 2 weeks in patients with rheumatoid arthritis, according to data presented at ACR Convergence 2022.